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Disturbance of hypothalamus–pituitary–adrenal axis activity is commonly reported in a range of mental
disorders in blood, saliva and urine samples. This study aimed to look at longer-term cortisol levels and
their association with clinical symptoms. Hair strands of 30 young people (16–25 years) presenting with
mental health problems (Mage7SD¼2172.4, 26 females) and 28 healthy controls (HC, Mage
7SD¼2072.9, 26 females) were analyzed for cortisol concentrations, representing the past 6 months
prior to hair sampling. Clinical participants completed an assessment on psychiatric symptoms, func-
tioning and lifestyle factors. All participants completed the Perceived Stress Scale. Hair cortisol con-
centrations representing the past 3 (but not 3–6) months were signiﬁcantly increased in clinical parti-
cipants compared to HC. Perceived stress in the past month was signiﬁcantly higher in clinical partici-
pants compared to HC, but not signiﬁcantly correlated with hair cortisol. Hair cortisol levels were not
signiﬁcantly associated with any other measures. Hair segment analyses revealed longer-term increased
levels of cortisol in the past 3 months in early mental health problems. Further insight into the role of
cortisol on the pathogenesis of mental illnesses requires longitudinal studies relating cortisol to psy-
chopathology and progression of illness.
& 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Disturbances in hypothalamus–pituitary–adrenal (HPA) axis
diurnal activity and responsivity are common ﬁndings in a range
of mental disorders (e.g. Yehuda et al., 1993; Meewisse et al., 2007;
Knorr et al., 2010). One of the most commonly reported para-
meters of the HPA axis is the glucocorticoid hormone cortisol.
Over- and under-activity of cortisol concentrations have been re-
ported by means of blood, saliva and urine samples in mood dis-
order (Cervantes et al., 2001; Vreeburg et al., 2009), psychosis
(Ryan et al., 2004), posttraumatic stress disorder (PTSD) (Yehuda
et al., 1990), panic (Bandelow et al., 2000) and generalized anxiety
disorder (GAD) (Mantella et al., 2008), somatization syndrome
(Rief et al., 1998), and eating (Monteleone et al., 2001) and sub-
stance use (Adinoff et al., 2003) disorders. Despite this, there is
considerable variability across (Yehuda et al., 1993) and within
diagnostic categories (for meta-analyses in PTSD, see Meewisse
et al. (2007), and depression, see Knorr et al. (2010)), which is whyIreland Ltd. This is an open acces
ity of Birmingham, Edgbastonit is important to investigate whether cortisol ﬂuctuations can be
explained by factors other than speciﬁc diagnostic categories, such
as inter-individual differences and stressor characteristics (Miller
et al., 2007).
Established analyses of cortisol in saliva, plasma and urine have
proven to be useful and reliable tools for documenting real-time
circulating cortisol levels (plasma, saliva) or mean cortisol excre-
tions over a speciﬁc time, usually 24 h (urine). In contrast, hair
cortisol represents a reliable, longer-term measure (generally up to
months) of stress and endogenous cortisol concentrations (Stalder
and Kirschbaum, 2012). The advantages of hair cortisol assessment
lie in providing a retrospective examination of hair cortisol levels
over an extended time period that is virtually impossible to
achieve with other methods. Moreover, it is a non-invasive sam-
pling method, samples can be easily stored at room temperature
for an extended period, and sampling avoids problems of ad-
herence which often experienced with other methods. However,
hair cortisol concentrations decrease from more proximal to distal
segments in human scalp hair, limiting the retrospective period of
examination (Stalder and Kirschbaum, 2012).
Considering a generally accepted human scalp hair growth rate
of 1 cm per month (Wennig, 2000) and taking hair samples from
the scalp near the posterior vertex region, this method allows fors article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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months (Dettenborn et al., 2012). Recent studies in clinical popu-
lations have demonstrated increased hair cortisol concentrations
in depression (Dettenborn et al., 2012), PTSD (Steudte et al.,
2011a), and in alcohol-dependent individuals (Stalder et al., 2010),
and decreases in GAD (Steudte et al., 2011b), and PTSD (Steudte
et al., 2013). Occupational impairment (i.e. unemployment) has
also been shown to be associated with increased hair cortisol
(Dettenborn et al., 2010). Strong test–retest associations for re-
peated hair cortisol measurements have been revealed, indicating
high intra-individual stability. Structural equation modelling
showed that, if no major life events or other stressors are present,
hair cortisol assessments comprise a strong trait component
which explains between 59% and 82% of variance in cortisol levels
(Stalder et al., 2012). A recent systematic review of hair analyses
revealed variations in hair cortisol (Staufenbiel et al., 2013) that
are similar to ﬁndings from meta-analyses and reviews on more
established cortisol measures (Meewisse et al., 2007; Knorr et al.,
2010). Despite some inconsistencies, hair cortisol appears to be
increased in depression, and decreased in anxiety disorders
(Staufenbiel et al., 2013).
The period of adolescence and young adulthood is character-
ized by increased vulnerability for the development of mental
disorders. Half of the lifetime cases of mental disorder start by age
14 and three quarters by age 24 (Kessler et al., 2005). It is hy-
pothesized that adolescence is accompanied by a biological sen-
sitivity to stress and that age-related cortisol increase may trigger
the expression of symptoms in vulnerable individuals (Walker
et al., 2010). Higher cortisol levels predict a higher risk of con-
version to psychotic disorder in at-risk individuals, providing
support for this hypothesis (Walker et al., 2010). The pathogenesis
of childhood anxiety disorders appears similar: high levels of
cortisol may induce changes to subcortical circuits, which may
make children vulnerable to developing anxiety symptoms (Muris,
2006). In one study, Rao et al. (2008) exposed adolescents with
depressive disorder and healthy controls (HC) to psychosocial
stress. Both groups showed increased cortisol levels, but in-
dividuals with depression displayed an increased and sustained
cortisol response. This supports the notion that stressful events
play a role in the development and maintenance of depressive
symptoms (Rao et al., 2008).
The time between the onset of the disorder (or stressful or
traumatic event) and hair collection appears to be a crucial ele-
ment in explaining the diversity of cortisol ﬁndings. Luo et al.
(2012) reported increased hair cortisol one month after a trau-
matic event in adolescents with PTSD, with levels decreasing after
7 months (for review, see Staufenbiel et al. (2013)). Increased
cortisol levels are therefore likely to reﬂect the on-going stress and
not the disorder itself (Staufenbiel et al., 2013). A signiﬁcant dif-
ference was observed between early- and late-onset bipolar dis-
order. Patients with a late onset disorder (Z30 years) presented
with higher hair cortisol than the early-onset group and HC
(Manenschijn et al., 2012). This ﬁnding suggests that early onset
bipolar disorder may be more strongly linked to a genetic vul-
nerability while late onset is usually triggered by life events and
stress (Staufenbiel et al., 2013). Taken together, these ﬁndings
suggest that HPA axis activity is elevated at the time of stressor
onset with declining cortisol levels as time passes (Miller et al.,
2007). However, the exact timeline of these hormonal changes is
unclear; that is, how long does the hypothesized cortisol increase
persist?
An alternative to explaining the heterogeneity of HPA axis
ﬁndings by classifying mental ill health into disorder-speciﬁc ca-
tegories is to use a dimensional approach. In this way, one can
examine symptom severity and consider a timeline of an in-
dividual's symptoms. One example of a dimensional approach is aclinical staging model. Within this framework, mental disorders
are assumed to develop from a pluripotential state, consisting of
undifferentiated general symptoms (such as depressive and anxi-
ety symptoms), and from a background of speciﬁc and non-speciﬁc
risk factors (McGorry et al., 2006; Lin et al., 2013), which are as-
sociated with non-speciﬁc distress (McGorry, 2013). This idea is
supported by the recent ﬁnding of a common mental distress
factor underlying depressive, anxiety, and psychotic phenomena in
adolescents (Stochl et al., 2015). It can therefore be inferred from
the clinical staging model that the early stages of mixed mental
health problems are likely to coincide with elevated cortisol levels.
However, to our knowledge, there has been no study investigating
longer-term cortisol levels in youth with early mental health
problems from a clinical staging perspective.
The aim of this study was to investigate the pathogenesis of
mental disorders in adolescents and young adults, and whether
diverse psychiatric symptoms are associated with altered longer-
term cortisol levels. We included young people who had sought
help for mental health problems, as well as HC. We wanted to test
the hypothesis that early stages of mental health problems are
associated with signiﬁcant distress (McGorry, 2013) and therefore
elevated cortisol levels. We further explored the association be-
tween cortisol levels and general psychological distress, depres-
sive, anxiety and psychotic symptoms, alcohol and tobacco use,
and childhood traumatic experiences.2. Methods
2.1. Participants
Thirty-one participants seeking help for mental health pro-
blems were recruited from the South Birmingham area via clinical
services (Youthspace & Birmingham Healthy Minds). Inclusion
criteria were being aged 16–25 years and recently help-seeking
(within 6 months of clinical contact) for mental health problems.
Youthspace is a youth-focused secondary mental health service
that provides support for youth aged 16–25 years. The service sees
young people with a variety of diagnoses and has no speciﬁc ex-
clusion criteria. Youthspace offer a variety of treatments and case
management is provided by a multi-disciplinary team. Birming-
ham Healthy Minds is a primary care psychological therapy ser-
vice, offering brief psychological talking therapy for individuals
aged 16 and above who present with depressive and anxiety
symptoms. Their exclusion criteria are bipolar disorder, psychosis,
suicidality or need for long-term care. At the time of recruitment,
both services operated primarily though GP referral. All clinical
participants from both services were generally eligible for the
study. Participants were recruited in one of three ways: (1) via
their clinician; (2) approached by the researcher in the waiting
room before or after their appointment at Youthspace; or (3) by
responding to a poster advertisement at these services. Not all
eligible individuals at the services were approached for partici-
pation. Reasons for this are because their clinicians may not have
felt that participation was appropriate (e.g. they were in crisis), or
because a researcher was not at the clinic on the days of their
appointments. Both services operated via multiple clinicians at
multiple sites, and therefore due to practical reasons, it was not
possible to gather statistics on refusal rates. However, not all ser-
vice users who were initially approached took part in the study.
Obtaining consent to partake meant in the ﬁrst instance, taking
part in an interview and self-report study focusing on mental
health symptoms, functioning and general life style factors. In the
second instance, individuals who either had a family history with
mental health problems in a ﬁrst-degree relative or who sub-
jectively did not improve concerning their well-being after six
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nate a hair sample.
Twenty-eight HC were recruited via university staff and local
advertisements at the University of Birmingham, United Kingdom.
HC were age, gender, occupation and education matched to the
clinical participants, and had no personal or ﬁrst-degree family
history of mental illness. A personal history was excluded based on
the Structured Clinical Interview for DSM-IV-TR (American Psy-
chiatric Association, 2000) Axis I Disorders.
Exclusion criteria for both groups were hair length of less than
3 cm at the posterior vertex region, a lack of sufﬁcient English or
cognitive ability to provide informed consent and adequately
complete assessments. The study was approved by the local re-
search ethics committee and participants provided written in-
formed consent.
2.2. Hair cortisol analyses
Hair strands of approximately 3 mm diameter were taken from
a posterior vertex position, as close to the scalp as possible. Cor-
tisol concentrations were determined from the 3 cm hair segment
most proximal to the scalp, and the following 3 cm segment in
accordance with the protocol of Stalder et al. (2012). Segments
were gently mixed with 2.5 ml isopropanol for three minutes.
After drying, 7.5 mg of whole, non-pulverized hair was incubated
in 1800 ml methanol for 18 h at 45 °C. Cortisol levels were de-
termined using a commercially available immunoassay with che-
miluminescence detection (CLIA, IBL-Hamburg, Germany).
2.3. Measures
Information on regular medication intake was collected and
covered exposure to contraceptive hormones (oral intake, patches
or implants) or glucocorticoids, and psychiatric medication (anti-
depressants, neuroleptics, betablockers, anticonvulsants) in the
past 6 months. All participants self-reported demographic and
hair-related information (number of hair washes per week, hair
treatments) and completed the 10-item Perceived Stress Scale
(PSS) (Cohen et al., 1983). The PSS evaluates the extent to which
situations in one's life are appraised as stressful and the degree to
which a person rates their life as unpredictable, uncontrollable and
overloading (Cohen et al., 1983). The clinical group additionally
completed an interview and self-report assessment on the fol-
lowing measures:
2.3.1. Comprehensive Assessment of At-Risk Mental States (CAARMS)
The CAARMS (Yung et al., 2005) is a semi-structured interview
designed to determine the at-risk for psychosis mental state. The
four subscales are Unusual Thought Content (e.g. delusional mood,
overvalued ideas), Non-Bizarre Ideas (e.g. suspiciousness, grandi-
osity), Perceptual Abnormalities (e.g. distortions, illusions, hallu-
cinations), Disorganized Speech (e.g. difﬁculties with speech and
communication) are rated on severity (0¼absent/never,
6¼psychotic and severe) and frequency (0¼absent/never,
6¼continuous) of psychotic symptoms. Severity and frequency
were summed to produce a total score across the four subscales.
Good to excellent agreement for intra-class correlation coefﬁcients
were reported for CAARMS subscales with an overall score for
inter-rater reliability of 0.85. CAARMS criteria displayed good
concurrent (e.g. with the Brief Psychotic Rating Scale) and pre-
dictive validity (e.g. higher risk of transition to psychosis in in-
dividuals with an at-risk mental state) (Yung et al., 2005).
2.3.2. Kessler Psychological Distress Scale (K-10)
The K-10 (Kessler et al., 2002) is a 10-item questionnaire as-
sessing psychological distress via questions about depressive andanxiety symptoms in the past 30 days. Items are rated on a 5-point
scale with total scores ranging from 10 to 50. The K-10 is a mod-
erately reliable instrument (kappa ranging from 0.42 to 0.74) (Dal
Grande et al., 2002) and demonstrates good concurrent validity
with other mental health instruments such as the General Health
Questionnaire and current diagnosis of anxiety and affective dis-
orders (Andrews and Slade, 2001).
2.3.3. Quick Inventory of Depressive Symptoms (QIDS)
The QIDS (Rush et al., 2003) is a 16-item, semi-structured in-
terview to gauge severity of depressive symptoms over the past
seven days. Items are scored 0–3 and total scores range from 0 to
27. A meta-analysis demonstrated acceptable psychometric prop-
erties with internal consistencies ranging from 0.65 to 0.87
(Chronbach's α) and concurrent validity (Reilly et al., 2015).
2.3.4. Ruminative style
Ruminative style was measured on a 10-item scale, requiring
participants to indicate on a 4-point scale how often they engage
with certain thoughts when they are feeling down or depressed
(Leach et al., 2008). Total scores range from 10 to 40.
2.3.5. Childhood Trauma Questionnaire, short form (CTQ-SF)
The CTQ-SF (Bernstein et al., 2003) is a 28-item instrument
generating information on traumatic childhood experiences using
a 5-point scale. Subscales are sexual, physical and emotional
abuse, and emotional and physical neglect, with subscale scores
from 5 to 25, and a total score from 25 to 125. The CTQ demon-
strates good internal consistencies with Chronbach's α ranging
from 0.79 to 0.94, and high retest-reliability over 6 months with
an intra-class correlation of 0.88, as well as concurrent validity
with the full CTQ (Bernstein et al., 1994,, 2003).
2.3.6. Overall Anxiety Severity and Impairment Scale (OASIS)
The OASIS (Campbell-Sills et al., 2009) is a brief 5-item ques-
tionnaire of severity and impairment across multiple anxiety dis-
orders and subthreshold anxiety. It captures frequency and in-
tensity of anxiety, avoidance behaviour and interference of anxiety
with everyday life and relationships. Total scores range from 0 to
20. The OASIS showed convergence with major anxiety measures,
a Chronbach's α of 0.84 for the ﬁve items (Campbell-Sills et al.,
2009), and one-month retest reliability of 0.82 (Norman et al.,
2006).
2.3.7. Psychosocial functioning
The Global Functioning: Social (Auther et al., 2006) and Role
(Niendam et al., 2006) Scales were used to index current social and
role functioning, providing overall scores from 1 to 10, with 10
indicating superior functioning and 1 extreme dysfunction. Inter-
rater reliability for social and role functioning ranged from 0.85 to
0.95, and the social functioning scale was signiﬁcantly correlated
with social contacts (r¼0.70) and role functioning with work and
school functioning (r¼0.57), demonstrating construct validity
(Cornblatt et al., 2007).
2.3.8. Lifestyle factors
Body mass index (BMI) was assessed. The frequency of smoking
and alcohol consumption in the past three months, and a total
score for tobacco and alcohol acuity as measured by the Alcohol,
Smoking and Substance Involvement Screening Test (ASSIST)
(Humeniuk et al., 2008) were provided. The ASSIST is a brief
screening questionnaire for hazardous, harmful and dependent
use of alcohol, tobacco and other psychoactive substances (can-
nabis, cocaine, amphetamines, sedatives, hallucinogens, inhalants,
opioids and other non-speciﬁed drugs). It provides information
about substances people may have ever used, used in the past
Table 1
Demographic and hair-related information on clinical participants and HC.
Clinical partici-
pants (n¼30)
HC
(n¼28)
Test statistic p-Value
Demographics
Age (M7SD) in
years
2172.4 2072.9 t (56)¼1.32 0.19
Gender (m/f) 4 (13%)/26 (87%) 2 (7%)/26
(93%)
χ2(1)¼0.6 0.44
Ethnicity
White 26 (87%) 16 (57%)
Asian 1 (3%) 5 (18%) χ2(3)¼8.9 0.03n
Black 2 (7%) 1 (4%)
Mixed-race 1 (3%) 6 (21%)
Occupation
University
studenta
9 (30%) 9 (32%)
College/A-Levels 9 (30%) 8 (29%) χ2(3)¼3.92 0.27
Unemployed 7 (23%) 2 (7%)
Employedb 5 (17%) 9 (32%)
Years of education
413 5 (17%) 7 (25%)
13 15 (50%) 14 (50%) χ2(2)¼0.83 0.66
o13 10 (33%) 7 (25%)
Hair-related
variables
Washes per week
(x ̃)
3.5 3.5 U¼372.5,
Z¼0.52
0.6
Hair treatmentc
(%)
63.3 42.9 χ2(1)¼2.44 0.12
Stress
questionnaire
PSS score, M7SD 26.174.5 1275.1 t (56)¼11.20 o0.001nnn
Notes. HC¼healthy controls, PSS¼Perceived Stress Scale.
a Undergraduate and postgraduate university students.
b Working full or part-time, volunteering, and non-paid internships.
c Hair treatment in the past 6 months (hair coloration, dye, and perm).
n po0.05.
nnn po0.001.
Table 2
Clinical measure, functioning scores and lifestyle factors of clinical participants.
Measure M7SD or Median Range
QIDS (n¼30) 10.37 4 4–20
Ruminative style (n¼29) 30.775.2 19–40
CAARMS (n¼30) 14.3710 0–30
K-10 (n¼30) 29.777.0 19–43
OASIS (n¼30) 8.974.6 0–17
CTQ-SF (n¼25) 50.4718.2 27–83
ASSIST alcohol (n¼30) 6.975.5 0–19
ASSIST smoking (n¼30) 3 0–31
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current and future harm and dependence. Scores ranging from 0 to
39 can be classiﬁed into low (for alcohol 0–10, all other substances
0–3), moderate (alcohol 11–26, other substances 4–26) and high
(all 27þ) substance acuity (Henry-Edwards et al., 2003). The cal-
culation of Cronbach's α revealed good inter-item correlation for
the individual scales ranging from 0.77 to 0.94. Concurrent validity
has been shown with the Addiction Severity Index with correla-
tions for scale scores ranging from 0.76 to 0.88 (Humeniuk et al.,
2008). No clinical participant reached a total score for any psy-
choactive substance (other than tobacco and alcohol) in the range
of moderate acuity or above (except moderate acuity for six clin-
ical participants for cannabis, and for two participants for seda-
tives), which did not allow for adequate statistical testing due to
small sample sizes.
2.4. Statistical analyses
Hair samples from 31 clinical participants and 28 HC were
collected. We initially approached 57 clinical participants (from
those who took part in the interview and self-report study) and 35
HC to donate hair samples. Five male and one female clinical
participant, and four male and three female HC could not parti-
cipate due to too short or too little hair. Whereas those males were
predominantly white-British, all four females were either mixed-
race or black-African. Fourteen of the other 21 participants initially
approached were either no longer contactable or did not want to
participate, two moved away after being approached, one was too
busy, and four did not meet criteria for another joint study (which
is why they were not asked to partake), resulting in an overall
refusal rate of 47%. Data of the ﬁrst hair segment of one clinical
participant was excluded due to an extreme outlier (490 stan-
dard deviations above the mean), providing data for 30 clinical
participants and 28 HC in the ﬁrst hair segment, and due to short
hair, data for 24 clinical participants and 24 HC on the second hair
segment. Cortisol data was positively skewed (skewness ﬁrst
segment¼2.6, skewness second segment¼3.73, kurtosis ﬁrst
segment¼7.65, kurtosis second segment¼19.24), but analyzed
using robust t-tests and analyses of covariance (ANCOVA).
Independent samples t-tests were performed for group com-
parisons of cortisol, age and PSS scores between clinical partici-
pants and HC, and between clinical participants taking anti-
depressants and those who were not, to discern whether anti-
depressant treatment could be associated with alterations in cor-
tisol concentrations. For categorical data, χ2-tests were used to
evaluate group differences. We conducted Spearman correlations
to discern associations of cortisol levels with clinical measures and
lifestyle factors in the clinical group, and for associations between
the ﬁrst and second hair segment. A paired samples t-test was
conducted to compare mean hair cortisol levels in the ﬁrst and
second segment, as well as a repeated measured analysis of var-
iance (ANOVA) to illustrate the interaction of cortisol levels over
time. ANCOVAwere employed to compare clinical participants and
HC, with ethnicity as a covariate, since groups differed signiﬁcantly
on ethnicity and it can be a confounding variable (Wennig, 2000;
Wosu et al., 2015).BMI (n¼28) 22.7 16.9–36.4
Smoking frequencya (n¼30) “Monthly” “Never”–“daily”
Alcohol consumptiona (n¼30) “Weekly” “Never”–“daily”
Notes. QIDS¼Quick Inventory of Depressive Symptoms, CAARMS¼Comprehensive
Assessment of At-Risk Mental States, K10¼Kessler Psychological Distress Scale,
OASIS¼Overall Anxiety Severity and Impairment Scale, ASSIST¼Alcohol, Smoking
and Substance Involvement Screening Test, BMI¼Body Mass Index, M¼mean
score, SD¼Standard deviation.
a Median scores for smoking and alcohol consumption frequency in the past
three months are calculated based on self-report data ranging from 0 (never), 2
(once or twice), 3 (monthly), 4 (weekly), and 6 (daily or almost daily).3. Results
3.1. Demographics and clinical description
Clinical participants and HC did not differ signiﬁcantly in terms
of age, gender, years of education and occupation, but differed
signiﬁcantly with regards to ethnicity (see Table 1). Median time
between gathering state-speciﬁc clinical measures (QIDS,CAARMS, K-10, OASIS, functioning, smoking, alcohol consumption,
BMI) and hair collection/gathering hair-related variables (PSS-
scores and medication intake, and demographics for HC) was 18.5
days (range 0–71 days). State-speciﬁc measures, along with data
on ruminative style, and childhood trauma are presented in
Table 2.
Twenty three clinical participants described their major mental
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Fig. 1. (A) Hair cortisol concentrations (1st segment) in clinical participants with mental health problems (n¼30) compared to healthy controls (HC; n¼28, p¼0.016);
(B) decrease in hair cortisol in clinical participants and HC from ﬁrst (nClinical¼24; nHC¼24) to second hair segment (nClinical¼24; nHC¼24).
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xiety, two as eating disorders, and one as obsessive-compulsive
disorder. Ten were classiﬁed as ultra-high risk for psychosis, 20
reported to have self-harmed and 18 had attempted suicide.
3.2. Hair cortisol and perceived stress: clinical participants vs HC
There was a signiﬁcant elevation of cortisol concentrations for
clinical participants compared to HC for the ﬁrst hair segment,
representing the past three months prior to sampling (t (56)¼
2.489, p¼0.016; d¼0.66) (see Fig. 1A). There were no group
differences in cortisol levels for the second segment represent-
ing the past three to six months prior to sampling (p¼0.495;
d¼0.2). Repeated analyses without individuals taking gluco-
corticoids did not change the ﬁndings for the ﬁrst (t(54)¼2.501,
p¼0.015) and second segment (p¼0.473). Clinical participants
perceived signiﬁcantly more stress in the past month compared
to HC (t(56)¼11.202, po0.001) (see Table 1); however, there
were no statistically signiﬁcant correlations between cortisol
concentrations in the ﬁrst segment and perceived stress, for the
whole sample (r¼0.219, p¼0.099) or groups compared in-
dividually (rClinical¼0.144, p¼0.448; rHC¼0.201, p¼0.305). Hair
cortisol of the ﬁrst and second hair segment correlated sig-
niﬁcantly with each other (r48¼0.286, p¼0.049). A paired-
samples t-test did not reveal a signiﬁcant decrease of cortisol
over time (t (47)¼1.601, p¼0.116). There was no signiﬁcant
Group Time interaction of cortisol levels (F (1, 46)¼1.704.
p¼0.20; see Fig. 1B). The main ﬁnding of elevated cortisol con-
centrations in the ﬁrst hair segment in clinical participants
compared to HC remained signiﬁcant after controlling for eth-
nicity (F (1, 55)¼4.77, p¼0.012).
3.3. Hair cortisol, clinical measures, functioning, and lifestyle
Hair cortisol concentrations in the ﬁrst and second segment
were not signiﬁcantly correlated with any of the investigated
clinical measures, social and role functioning or lifestyle measures
(all p40.05).
3.4. Hair cortisol and medication
Both groups were matched in terms of glucocorticoid and
contraceptive hormone use, making this unlikely to account for
group differences in cortisol in the ﬁrst hair segment: One clinical
participant and one HC were using glucocorticoids at the time of
hair collection, of which neither produced abnormally elevated
cortisol levels in either hair segment. 24% of the clinicalparticipants and 36% of HC were exposed to contraceptive hor-
mones at the time of hair collection.
72% of the clinical participants were taking antidepressants,
3.4% neuroleptics, 3.4% anti-convulsive medication, and 3.4% were
taking beta-blockers at the time of hair collection. There were no
signiﬁcant differences for cortisol levels in the ﬁrst (1st) and sec-
ond hair (2nd) segment in those clinical participants taking anti-
depressants and/or other psychiatric medication (n1st¼21;
n2nd¼16) compared to those patients who were not (n1st¼9;
n2nd¼8) (p40.05).4. Discussion
In the present study, we identiﬁed elevated hair cortisol con-
centrations representing the past three months prior to hair
sampling in adolescents and young adults with mental health
problems compared to healthy participants. We also found ele-
vated perceived stress in clinical participants, but there was no
association between cortisol and subjective stress experience.
There were no signiﬁcant correlations between cortisol and clin-
ical measures, functioning and lifestyle factors.
Our ﬁnding of longer-term elevated cortisol levels in young
individuals with mental health problems is in line with the pre-
sumption of the experience of non-speciﬁc but signiﬁcant psy-
chological distress in the early stages of mental health problems
(McGorry, 2013), and therefore with a dimensional approach to
emerging mental health disorders such as a clinical staging model
(McGorry et al., 2006; Lin et al., 2013). We conﬁrmed that this
state of undifferentiated symptoms in the early stages of a mental
health disorder is associated with an increase in cortisol and self-
reported stress levels. However, whether decreases in cortisol le-
vels coincide with illness progression (dependent or independent
of diagnostic category), and whether cortisol levels decline (to
normal) with remission of symptoms, remains to be investigated
longitudinally.
Our clinical participants were experiencing mental health
problems for at least six months, although had only recently
sought help. The time when the young people started seeking help
can be seen as a crisis point, when their problems started to
worsen (possibly due to a signiﬁcant event or stressor), explaining
elevated cortisol only in the past three months. Although there
was no signiﬁcant time-by-group interaction, visual inspection of
the data suggest a much more pronounced increase in cortisol
level for the clinical group. This non-signiﬁcance may be due to
washout effects (Kirschbaum et al., 2009) and variable, inter-in-
dividual rates of hair growth (Wennig, 2000) that may limit the
K. Heinze et al. / Psychiatry Research 236 (2016) 98–104 103detection of differences in the more distal hair segment. This null
ﬁnding may also have been due to insufﬁcient statistical power.
In most previous studies, individuals with full-blown mental
disorders (usually at the chronic stage) have been investigated,
whereas the current sample included help-seeking youth in the
early stages of mental health problems. Speciﬁc patterns of hair
cortisol alterations were reported in previous studies, e.g. in-
creases in depression (Dettenborn et al., 2012), and (if diagnosis
sustained at least in the medium-term) decreases in PTSD (Steudte
et al., 2013). However, we did not note correlations of cortisol with
speciﬁc clinical measures (e.g. depressive, anxiety or psychotic
symptoms). Given the relatively small sample size, but highly
heterogeneous and comorbid sample in terms of clinical symp-
toms, it is conceivable that the results were masked by the inter-
action of symptoms with each other. For example, traumatic ex-
periences in childhood might result in reduced cortisol levels
while depressive symptoms result in increased cortisol, thus can-
celling each other out. Furthermore, previous studies included
clinical participants with more severe symptoms than in our
sample; the more narrow range in the current study may have
prevented the detection of correlations with cortisol.
The lack of correlations between hair cortisol and perceived
stress in this study, is not an uncommon ﬁnding (Hjortskov et al.,
2004; Stalder and Kirschbaum, 2012; Staufenbiel et al., 2013). Al-
ternative explanations for this lack of association between cortisol
and the PSS are the mismatch of time frame of one month for the
PSS and 3 months for the ﬁrst hair segment, or possibly the lack of
validity of perceived stress in increasing hair cortisol concentra-
tions (Staufenbiel et al., 2013). It is plausible that only certain
characteristics of stressors lead to an endocrine response, which
may have not been reﬂected using the PSS (Hjortskov et al., 2004).
It has been shown that hair cortisol alterations are implicated in
a variety of health conditions (Staufenbiel et al., 2013), which is
consistent with the ﬁnding of elevated cortisol in our sample of
individuals with a range of mental health symptoms and disorders.
Even though there is some evidence that cortisol might contribute
to the aetiology of psychiatric conditions such as depressive
symptoms (Johnson et al., 2006), the most plausible explanation
appears to be a reciprocal relationship between stress promoting
the development of mental disorders and psychiatric conditions
being naturally accompanied by distress and cortisol increase.
4.1. Limitations
A limitation of this study is that clinical measures were not
administered at the same time as the hair sample, although we
aimed to collect clinical and cortisol data as close together as
possible. A possible explanation for the lack of association be-
tween cortisol and perceived stress and other measures is that
they did not entirely correspond with the window of cortisol de-
tection. Although the median time from clinical assessment to
cortisol measurement was only 18.5 days, cortisol measurements
corresponded approximately with the past three and three to six
months, whereas some self-reported and interview measures
captured information from the previous week or month only. The
HC group did not receive clinical assessments, therefore we were
not able to use these clinical variables, functioning and lifestyle
factors as covariates in our analyses. HC did not present with any
threshold DSM disorder, however, we cannot fully rule out the
inﬂuence of sub-threshold distress or disorders in this group.
In terms of feasibility and refusal rates of this study is im-
portant to mention that more males and more mixed-race women
did not participate. Our clinical group included signiﬁcantly more
white individuals than the control group, whereas controls in-
cluded more non-white (e.g. Asian and mixed-race) participants.
Wosu et al. (2015) found differences in hair cortisol levelsaccording to ethnicity, with lower levels in white participants.
However, since our clinical group included more white partici-
pants, ethnicity is unlikely to account for our main ﬁnding of
elevated hair cortisol. It is further unlikely that increased cortisol
levels in the clinical group were due to antidepressant intake, as
there were no differences in hair cortisol between those clinical
participants who were taking antidepressant medication and
those who were not. Furthermore, we were not able to obtain
statistics on the representativeness of our clinical population; that
is, what proportion of service users decided to take part in the
study. Also, this study is only representative for young help-
seeking people who either have a family history of mental health
problems or whose problems are sustained for at least 6 weeks.
A relatively small sample size is a further limitation, although
we found, as hypothesized, a group difference in hair cortisol
concentration in the ﬁrst segment. Given the clinical heterogeneity
of the sample, the sample size was not sufﬁcient to conduct sub-
group analyses (e.g. comparing different types of anxiety dis-
orders, or clinical stages). Differentiation of speciﬁc mental dis-
orders on the basis of increases or decreases in cortisol [as seen in
previous studies, e.g. for review, see Staufenbiel et al. (2013)] is
more likely to occur where there is persistence and progression of
symptoms, and therefore more likely to be distinguished over the
future course of illness in this population.
Lastly, we cannot rule out the inﬂuence of recreational tobacco
use, alcohol consumption, and use of psychoactive illegal drugs on
hair cortisol levels. We did not ﬁnd an association between hair
cortisol and alcohol and tobacco use in the past three months, nor
an association with tobacco- and alcohol-related problems or be-
haviours. Parrott et al. (2014) found an almost 4-fold increase in
hair cortisol levels in regular ecstasy users as compared to non-
users. However, the sample size was too small to conduct mean-
ingful analyses with any illegal psychoactive drugs.
4.2. Conclusions and future directions
We found elevated hair cortisol levels in young people with
diverse mental health problems, which is consistent with the
ﬁnding of increased HPA axis activity with stressor onset, or in our
case, in the early stages of help-seeking for mental health pro-
blems. Future research should focus on disentangling how actual
life stressors and subjective stress experience are associated with
increases in cortisol and the development and maintenance of
mental disorders, and how HPA axis activity develops and adapts
over the course of illness and with remission of symptoms.Financial disclosures
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